Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Blend |
| Morningstar category | Foreign Large Blend |
| Launch date | 21 Dec 2015 |
| Price currency | USD |
| Domicile | United States |
| Symbol | STEZX |
| Manager & start date | Stuart Rae 21 Dec 2015 Vivian Chen 23 Jan 2023 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 7.74bn USD As of Apr 30 2024 |
| Share class size | 858.79m USD As of Apr 30 2024 |
| Net expense ratio | 0.73% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 0.00 USD |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 15.13% | 16.63% | 0.00% | 16.63% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Novo Nordisk A/S NOVO B:CPH | +57.10% | 4.98% | |
| Taiwan Semiconductor Manufacturing Co Ltd 2330:TAI | +56.95% | 3.47% | |
| Wolters Kluwer WKL:AEX | +35.26% | 2.75% | |
| GSK plc GSK:LSE | +24.67% | 2.72% | |
| LVMH Moet Hennessy Louis Vuitton SE MC:PAR | -10.89% | 2.71% | |
| Per cent of portfolio in top 5 holdings: 16.63% |
Asset type
| Non-US stock | 94.87% |
| US stock | 4.48% |
| Cash | 0.65% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.00% |
Top 5 sectors
| Industrials | 19.46% |
| Financial Services | 19.21% |
| Consumer Cyclical | 17.10% |
| Technology | 15.95% |
| Healthcare | 9.54% |
| Other | 18.09% |
Top 5 regions
| Eurozone | 29.53% |
| Japan | 18.90% |
| Developed Asia | 14.01% |
| United Kingdom | 11.02% |
| Europe - ex Euro | 7.17% |
| Other | 18.72% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
